We evaluated p53 activities in primary glioma cultures and established glioma cell lines by transfecting cells with plasmids carrying the luciferase reporter gene under the control of a p53-responsive (pPG13-Luc) or mutated promoter (pMG13-Luc, with mutated p53 binding sites). Here, TP53 is linked to central nervous system cancer.